Targeted therapy of hepatocellular carcinoma by histone deacetylase inhibitor and preliminary study on the targeted imaging probe [18F]FAHA.
碩士 === 國立陽明大學 === 生物醫學影像暨放射科學系 === 101 === Histone deacetylase (HDAC) inhibitors are emerging as a new class of anticancer agents. Recent studies have shown HDACIs have notable effects on cell proliferation, apoptosis, differentiation and angiogenesis in vitro and in vivo. Currently, there are pha...
Main Authors: | Yi-Shiuan Chen, 陳懿璿 |
---|---|
Other Authors: | Ran-Chou Chen |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/60667104232816495752 |
Similar Items
-
Dual Inhibitors Targeting DNA and Histone Deacetylases
by: Chen Chen, et al.
Published: (2020-06-01) -
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01) -
Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies
by: Chao Ma, et al.
Published: (2021-09-01) -
Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
by: Nikolaos Garmpis, et al.
Published: (2021-03-01) -
Targeted histone deacetylase inhibition
by: Guerrant, William
Published: (2012)